NCT03997747View on ClinicalTrials.gov

Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

August 13, 2019

Primary Completion Date

October 1, 2021

Study Completion Date

December 1, 2021

Conditions
Osteosarcoma
Interventions
OTHER

cytology specimen

Biopsy and Genetic: DNA analysis;Genetic: RNA analysis;Genetic: microarray analysis; Genetic: mutation analysis; Genetic: polymorphism analysis

Trial Locations (2)

100044

Peking University People's Hospital, Beijing

Unknown

Peking University Shougang Hospital, Beijing

Sponsors

Collaborators (1)

OrigiMed
All Listed Sponsors
collaborator

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

collaborator

OrigiMed

INDUSTRY

lead

Peking University People's Hospital

OTHER

NCT03997747 - Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS | Biotech Hunter | Biotech Hunter